Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...

Related Keywords

New Zealand ,Switzerland ,Israel ,Hong Kong ,United Kingdom ,Singapore ,China ,Quebec ,Canada ,Australia ,Toronto ,Ontario ,Macau ,United States ,Taiwan ,Canadian ,Dara Willis ,Inbal Chen ,Medison Pharma ,Albiruni Razak ,Pamela Minden ,Health Canada ,Gage Communications ,Princess Margaret Cancer Centre ,European Union ,Deciphera Pharmaceuticals ,Corporate Communications ,Sarcoma Life Raft Group Canada ,Health Benefits ,Non Insured Health Benefits ,Country Manager ,Medical Oncologist ,Mount Sinai ,Product Monograph ,Life Raft Group Canada ,Accessed September ,